Regulation effects on the adoption of new medicines
Year of publication: |
2015
|
---|---|
Authors: | Costa-Font, Joan ; McGuire, Alistair ; Varol, Nebibe |
Published in: |
Empirical economics : a journal of the Institute for Advanced Studies, Vienna, Austria. - Berlin : Springer, ISSN 0377-7332, ZDB-ID 519394-1. - Vol. 49.2015, 3, p. 1101-1121
|
Subject: | Pharmaceutical innovation | Medicines adoption | Regulation | Duration analysis | Regulierung | Arzneimittel | Pharmaceuticals | Innovationsdiffusion | Innovation diffusion | Pharmaindustrie | Pharmaceutical industry | Innovation | Arzneimittelmarkt | Pharmaceutical market |
-
Estimating the cost of strategic entry delay in pharmaceuticals : the case of Ambien CR
Shapiro, Bradley T., (2016)
-
Unpacking the effects of adverse regulatory events : Evidence from pharmaceutical relabeling
Higgins, Matthew J., (2021)
-
The diffusion of generics after patent expiry in Germany
Blankart, Katharina, (2016)
- More ...
-
Price regulation and relative delays in generic drug adoption
Costa-Font, Joan, (2014)
-
Varol, Nebibe,
-
Does Adoption of Pharmaceutical Innovation Respond to Changes in the Regulatory Environment?
Varol, Nebibe, (2012)
- More ...